Fig. 5From: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosisRAND SF-36 quality of life scores compared to baseline. Scores for the RAND SF-36 question capture health change. Scores were compared with baseline at the 1-month and 1-year visits. N = 20 at 1 month (same as baseline), N = 17 at 1 yearBack to article page